文献速递慢阻肺

专科慢阻肺门诊中吸气峰流量与吸入器处方策略的真实世界观察

Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.
PubMed 文献 · Chest · 2024-10-09

单中心真实世界观察研究在专科慢阻肺门诊系统测量吸气峰流量(PIF)并提供即时结果。161例中28%存在次优PIF,11.2%吸入器与实测PIF不匹配,女性、低FEV1和低BMI与次优PIF相关,即时PIF可影响临床决策。

要点

  • 专科慢阻肺门诊中28%患者存在次优PIF,11.2%吸入器与实测PIF不匹配。
  • 女性、较低FEV1和低BMI是次优PIF的重要且易识别风险因素。
  • 即时PIF结果可影响吸入器处方决策,尤其在不匹配或非单一/相似装置方案者中。

核心结论

  • 专科慢阻肺门诊中次优PIF和吸入器与实测PIF不匹配均较常见。
  • 女性、较低FEV1和低BMI是次优PIF的重要且易识别风险因素。
  • 即时PIF可影响临床决策。

研究设计与样本

  • 单中心真实世界观察研究,在专科慢阻肺门诊每次随访系统测量PIF并向临床医生提供即时结果。
  • 共纳入161例门诊参与者。

主要发现

  • 161例中45例(28%)存在次优PIF,18例(11.2%)吸入器与实测PIF不匹配。
  • 次优PIF与年龄(1.09;95%CI,1.04-1.15)、女性(10.30;95%CI,4.45-27.10)、身高(0.92;95%CI,0.88-0.96)、BMI(0.90;95%CI,0.84-0.96)和FEV1(0.09;95%CI,0.03-0.26)显著相关。
  • 校正年龄和性别后,次优PIF与BMI的关联仍显著,而与身高的关联不再显著。
  • 50例(31.1%)为非单一吸入器治疗(non-SIT)和/或不相似装置;59例(36.6%)方案为吸入器与实测PIF不匹配和/或非SIT/不相似装置。
  • 在上述59例中观察到吸入器处方改变(3.39;95%CI,1.76-6.64),在已有SIT/相似方案但PIF次优者中亦观察到处方改变(2.93;95%CI,1.07-7.92)。

临床怎么用

  • 在专科慢阻肺门诊可系统测量PIF,并将即时结果用于吸入器处方决策。
  • 对女性、较低FEV1或低BMI的慢阻肺患者,应关注次优PIF风险并评估吸入器适用性。

局限性

  • 单中心真实世界观察研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD inhaler regimens should be appropriate for the patient's peak inspiratory flow (PIF) and should ideally consist of single or similar device(s). RESEARCH QUESTIONS: In a subspecialized COPD clinic: (1) What is the prevalence of patients with suboptimal PIF and with inappropriate device(s) for measured PIF? (2) Are there patient-related risk factors associated with suboptimal PIF? (3) What is the prevalence of patients with non-single inhaler therapy (SIT)/nonsimilar devices? (4) Does point-of-care PIF affect clinical decision-making? STUDY DESIGN AND METHODS: In this single-center real-world observational study, PIF was measured systematically at every outpatient visit in a subspecialized COPD clinic, and point-of-care results were provided to the clinician. Coprimary outcomes were the prevalence of outpatients with suboptimal PIF and with inappropriate devices for measured PIF. Secondary outcomes were patient-related risk factors associated with suboptimal PIF, the prevalence of non-SIT/nonsimilar devices, the prevalence of regimens consisting of either inappropriate device(s) for measured PIF and/or non-SIT/nonsimilar devices, and the effect of point-of-care PIF on clinical decision-making. RESULTS: Suboptimal PIF was identified in 45 of 161 participants (28%), and inappropriate device(s) for measured PIF were identified in 18 participants (11.2%). Significant associations were observed between suboptimal PIF and age (1.09; 95% CI, 1.04-1.15), female sex (10.30; 95% CI, 4.45-27.10), height (0.92; 95% CI, 0.88-0.96), BMI (0.90; 95% CI, 0.84-0.96), and FEV1 (0.09; 95% CI, 0.03-0.26). After adjustment for age and sex, the association between suboptimal PIF and BMI, but not height, remained significant. Non-SIT and/or nonsimilar devices were identified in 50 participants (31.1%). Regimens consisting of either inappropriate device(s) for measured PIF and/or non-SIT/nonsimilar devices were observed in 59 participants (36.6%). Inhaler prescription changes were observed in this latter group (3.39; 95% CI, 1.76-6.64), as well as in patients with suboptimal PIF who already had SIT/similar regimens (2.93; 95% CI, 1.07-7.92). INTERPRETATION: Suboptimal PIF and inappropriate devices for measured PIF were highly prevalent among outpatients from a subspecialized COPD clinic. Our results show that female sex, reduced FEV1, and low BMI are important, readily identifiable risk factors for suboptimal PIF, and point-of-care PIF can inform clinical decision-making.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pankovitch S, Frohlich M, AlOthman B, et al. Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study. Chest. 2024. PMID: 39384100. doi:10.1016/j.chest.2024.09.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。